Oliver D J, Frayne J R, Sterrett G
Sir Charles Gairdner Hospital, Nedlands, Perth, Australia.
Aust N Z J Surg. 1992 Jun;62(6):463-7. doi: 10.1111/j.1445-2197.1992.tb07226.x.
The experience of the use of the TRC-Mammotest machine for stereotactic fine needle biopsy (SFNB) of the breast in Perth is presented. During the period 20 October 1988 to 10 January 1990, 404 SFNB were performed on 389 women with impalpable, mammographically detected lesions of the breast. Surgical biopsy was performed in 73 cases, of which 38 were malignant, giving a benign to malignant ratio in less than 1:1. The sensitivity for detecting cancer was 95%, with a positive predictive value of 100%. Using a combination of the mammographic and cytologic rating for the likelihood of cancer, all the cancers were detected and no cancers have developed in those considered mammographically and cytologically benign. The importance of a combined assessment of mammography and cytology in the management of patients with mammographically detected abnormalities is stressed.
本文介绍了在珀斯使用TRC - Mammotest机器进行乳腺立体定向细针穿刺活检（SFNB）的经验。在1988年10月20日至1990年1月10日期间，对389名乳房有钼靶检测到但触诊不到病变的女性进行了404次SFNB。73例进行了手术活检，其中38例为恶性，良性与恶性比例小于1:1。检测癌症的敏感性为95%，阳性预测值为100%。结合钼靶和细胞学对癌症可能性的评级，所有癌症均被检测到，且在钼靶和细胞学检查均为良性的患者中未发生癌症。强调了钼靶和细胞学联合评估在管理钼靶检测到异常的患者中的重要性。
